Close

Inovio Pharma (INO) Receives $6.1M Sub-Grant from The Wistar Institute for Zika Infection Treatment

December 1, 2016 9:06 AM EST Send to a Friend
Inovio Pharmaceuticals, Inc. (Nasdaq: INO) announced that it has been awarded a $6.1 million sub-grant through The Wistar Institute to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login